Medical Disposables & Supplies Limited (JMSE:MDS)

Sage Therapeutics Statistics

Total Valuation

JMSE:MDS has a market cap or net worth of JMD 394.74 million. The enterprise value is 1.46 billion.

Market Cap	394.74M
Enterprise Value	1.46B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

JMSE:MDS has 263.16 million shares outstanding.

Current Share Class	263.16M
Shares Outstanding	263.16M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.24%
Owned by Insiders (%)	78.80%
Owned by Institutions (%)	4.80%
Float	55.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.10
PB Ratio	0.65
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.23
EV / Sales	0.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.07

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.79.

Current Ratio	1.12
Quick Ratio	0.43
Debt / Equity	1.79
Debt / EBITDA	n/a
Debt / FCF	-20.77
Interest Coverage	-0.99

Financial Efficiency

Return on equity (ROE) is -37.80% and return on invested capital (ROIC) is -5.17%.

Return on Equity (ROE)	-37.80%
Return on Assets (ROA)	-3.58%
Return on Invested Capital (ROIC)	-5.17%
Return on Capital Employed (ROCE)	-15.77%
Revenue Per Employee	38.84M
Profits Per Employee	-2.02M
Employee Count	100
Asset Turnover	1.47
Inventory Turnover	2.76

Taxes

Income Tax	-3.27M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.92% in the last 52 weeks. The beta is -0.16, so JMSE:MDS's price volatility has been lower than the market average.

Beta (5Y)	-0.16
52-Week Price Change	-18.92%
50-Day Moving Average	1.48
200-Day Moving Average	1.77
Relative Strength Index (RSI)	51.63
Average Volume (20 Days)	18,046

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, JMSE:MDS had revenue of JMD 3.88 billion and -201.83 million in losses. Loss per share was -0.77.

Revenue	3.88B
Gross Profit	876.43M
Operating Income	-151.66M
Pretax Income	-284.33M
Net Income	-201.83M
EBITDA	-113.25M
EBIT	-151.66M
Loss Per Share	-0.77

Balance Sheet

The company has 50.93 million in cash and 1.08 billion in debt, giving a net cash position of -1.03 billion or -3.91 per share.

Cash & Cash Equivalents	50.93M
Total Debt	1.08B
Net Cash	-1.03B
Net Cash Per Share	-3.91
Equity (Book Value)	603.11M
Book Value Per Share	2.16
Working Capital	186.61M

Cash Flow

In the last 12 months, operating cash flow was -46.20 million and capital expenditures -5.81 million, giving a free cash flow of -52.01 million.

Operating Cash Flow	-46.20M
Capital Expenditures	-5.81M
Free Cash Flow	-52.01M
FCF Per Share	-0.20

Margins

Gross margin is 22.56%, with operating and profit margins of -3.90% and -5.20%.

Gross Margin	22.56%
Operating Margin	-3.90%
Pretax Margin	-7.32%
Profit Margin	-5.20%
EBITDA Margin	-2.92%
EBIT Margin	-3.90%
FCF Margin	n/a

Dividends & Yields

JMSE:MDS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-51.13%
FCF Yield	-13.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

JMSE:MDS has an Altman Z-Score of 1.77 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.77
Piotroski F-Score	4